Clinical trial
Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
NCT00272753 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00272753 |
|---|---|
| Title | Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations |
| Official title | A Randomized Double Blind Comparison Between Single Doses of Symbicort Turbuhaler (Budesonide/Formoterol Combination), Formoterol, Salbutamol and Placebo in Repeated AMP-challenges in Patients With Mild - to Moderate Asthma. Investigating the Supplementary Value of the Budesonide Component Within… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | budesonide/formoterol Turbuhaler, formoterol Turbuhaler, salbutamol |
| Enrollment | 20 |
| Start date | Apr 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Jan 9, 2006 |
| Last update posted | Jun 1, 2011 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: